This inventor holds 21 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Antiviral Compounds. Top assignees: Gilead Sciences, Inc., Essential Therapeutics, Inc., Schering-Plough Animal Health Corporation. Active years: 2002-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Franciso, CA (US) (2015)
- San Francisco, CA (US) (2002 - 2018)
Company Filing History:
19 out of 946 
1 out of 12 
1 out of 30 
Years Active: 2002-2018
Areas of Expertise:
Title: The Innovations of Constantine G Boojamra
Introduction:
Constantine G Boojamra, a prolific inventor based in San Francisco, CA, has made significant contributions to the field of antiviral treatments through his innovative patents. With a total of 21 patents to his name, Boojamra's work has had a profound impact on the medical community.
Latest Patents:
Boojamra's latest patents include groundbreaking inventions such as "Pyrazolo[1,5-A]pyrimidines for antiviral treatment." These compounds are designed to treat Pneumovirinae virus infections, particularly Human respiratory syncytial virus infections. Additionally, he has developed "Phosphonate analogs of HIV inhibitor compounds," which are crucial in the fight against HIV.
Career Highlights:
Throughout his career, Boojamra has worked with reputable companies like Gilead Sciences, Inc. and Schering-Plough Animal Health Corporation. His expertise and dedication have led to the development of cutting-edge pharmaceutical solutions that are vital in the battle against infectious diseases.
Collaborations:
Boojamra has collaborated with esteemed professionals in the industry, including Richard L Mackman and David Y Markevitch. Together, they have advanced the field of antiviral research and paved the way for new and improved treatment options.
Conclusion:
In conclusion, Constantine G Boojamra stands out as a pioneering inventor in the realm of antiviral treatments. His patents not only showcase his innovative spirit but also highlight his commitment to improving global healthcare. Boojamra's contributions continue to shape the landscape of medical innovation, making him a true trailblazer in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile